CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands		Total	Common Stock	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive (Loss) Income	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2023			16,998,929
Beginning balance at Dec. 31, 2023		$ 542,350	$ 16,999		$ 405,725	$ 145,982	$ (16,637)	$ (9,719)
Net income		12,133				12,133
Total other comprehensive income (loss)		(310)					(310)
Common stock cash dividends declared, $0.20 per share		(3,314)				(3,314)
Repurchased stock		(323)						(323)
Employee Stock Purchase Plan (in shares)			5,653
Employee Stock Purchase Plan		112	$ 5		107
Director Stock Purchase Plan (in shares)			1,777
Director Stock Purchase Plan		36	$ 2		34
Restricted stock activity		284			284
Ending balance (in shares) at Mar. 31, 2024			17,006,359
Ending balance at Mar. 31, 2024		550,968	$ 17,006		406,150	154,801	(16,947)	(10,042)
Beginning balance (in shares) at Dec. 31, 2023			16,998,929
Beginning balance at Dec. 31, 2023		542,350	$ 16,999		405,725	145,982	(16,637)	(9,719)
Net income		36,205
Total other comprehensive income (loss)		3,521
Ending balance (in shares) at Sep. 30, 2024			17,060,896
Ending balance at Sep. 30, 2024		573,059	$ 17,061		406,922	172,234	(13,116)	(10,042)
Beginning balance (in shares) at Mar. 31, 2024			17,006,359
Beginning balance at Mar. 31, 2024		550,968	$ 17,006		406,150	154,801	(16,947)	(10,042)
Net income		11,771				11,771
Total other comprehensive income (loss)		(176)					(176)
Common stock cash dividends declared, $0.20 per share		(3,316)				(3,316)
Employee Stock Purchase Plan (in shares)			5,123
Employee Stock Purchase Plan		103	$ 5		98
Director Stock Purchase Plan (in shares)			1,389
Director Stock Purchase Plan		30	$ 1		29
Restricted stock activity (in shares)			38,365
Restricted stock activity		306		$ 39	267
Ending balance (in shares) at Jun. 30, 2024			17,051,236
Ending balance at Jun. 30, 2024		559,686	$ 17,051		406,544	163,256	(17,123)	(10,042)
Net income		12,301				12,301
Total other comprehensive income (loss)		4,007					4,007
Common stock cash dividends declared, $0.20 per share		(3,323)				(3,323)
Employee Stock Purchase Plan (in shares)			5,565
Employee Stock Purchase Plan		122	$ 6		116
Director Stock Purchase Plan (in shares)			1,021
Director Stock Purchase Plan		31	$ 1		30
Restricted stock activity (in shares)			3,074
Restricted stock activity		235		3	232
Ending balance (in shares) at Sep. 30, 2024			17,060,896
Ending balance at Sep. 30, 2024		$ 573,059	$ 17,061		406,922	172,234	(13,116)	(10,042)
Beginning balance (in shares) at Dec. 31, 2024		19,355,797	19,796,519
Beginning balance at Dec. 31, 2024		$ 655,018	$ 19,797		480,491	181,597	(16,825)	(10,042)
Net income		13,742				13,742
Total other comprehensive income (loss)		2,662					2,662
Common stock cash dividends declared, $0.20 per share		(3,870)				(3,870)
Employee Stock Purchase Plan (in shares)			5,311
Employee Stock Purchase Plan		137	$ 5		132
Director Stock Purchase Plan (in shares)			986
Director Stock Purchase Plan		26	$ 1		25
Restricted stock activity		218			218
Ending balance (in shares) at Mar. 31, 2025			19,802,816
Ending balance at Mar. 31, 2025		$ 667,933	$ 19,803		480,866	191,469	(14,163)	(10,042)
Beginning balance (in shares) at Dec. 31, 2024		19,355,797	19,796,519
Beginning balance at Dec. 31, 2024		$ 655,018	$ 19,797		480,491	181,597	(16,825)	(10,042)
Net income		36,801
Total other comprehensive income (loss)		$ 7,918
Ending balance (in shares) at Sep. 30, 2025		23,039,223	23,550,614
Ending balance at Sep. 30, 2025		$ 796,323	$ 23,551		588,405	205,320	(8,907)	(12,046)
Beginning balance (in shares) at Mar. 31, 2025			19,802,816
Beginning balance at Mar. 31, 2025		667,933	$ 19,803		480,866	191,469	(14,163)	(10,042)
Net income		4,762				4,762
Total other comprehensive income (loss)		2,407					2,407
Common stock cash dividends declared, $0.20 per share		(4,657)				(4,657)
Common stock issued in business combination (in shares)	[1]		3,506,795
Common stock issued in business combination	[1]	103,206	$ 3,507		99,699
Stock options exercised (in shares)			31,323
Stock options exercised		3,364	$ 31		3,333
Repurchased stock		(1,778)						(1,778)
Employee Stock Purchase Plan (in shares)			4,636
Employee Stock Purchase Plan		120	$ 5		115
Director Stock Purchase Plan (in shares)			901
Director Stock Purchase Plan		25	$ 1		24
Restricted stock activity (in shares)			72,257
Restricted stock activity		326		72	254
Ending balance (in shares) at Jun. 30, 2025			23,418,728
Ending balance at Jun. 30, 2025		775,708	$ 23,419		584,291	191,574	(11,756)	(11,820)
Net income		18,297				18,297
Total other comprehensive income (loss)		2,849					2,849
Common stock cash dividends declared, $0.20 per share		(4,551)				(4,551)
Stock options exercised (in shares)			108,548
Stock options exercised		3,161	$ 109		3,052
Repurchased stock		(226)						(226)
Employee Stock Purchase Plan (in shares)			5,067
Employee Stock Purchase Plan		145	$ 5		140
Director Stock Purchase Plan (in shares)			893
Director Stock Purchase Plan		26	$ 1		25
Restricted stock activity (in shares)			17,378
Restricted stock activity		$ 914		$ 17	897
Ending balance (in shares) at Sep. 30, 2025		23,039,223	23,550,614
Ending balance at Sep. 30, 2025		$ 796,323	$ 23,551		$ 588,405	$ 205,320	$ (8,907)	$ (12,046)

[1] Shares issued on April 30, 2025 as a result of the William Penn acquisition. See "Note 2 - Business Combinations" to the Consolidated Financial Statements for more information.